Clinical Trial Update: Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating hedgehog inhibitors for metastatic pancreatic cancer completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Hedgehog inhibitors (null)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-04-26